Quarterly report · Q1
2533.TEDINET S100QO6N
Period2023-01-01 → 2023-03-31
Filed2023-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥20.8bn | 2023-01-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥81.1bn | 2022-01-01 → 2022-12-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥17.5bn | 2022-01-01 → 2022-03-31 | Cons. | Net sales |
| Operating income | ¥876m | 2023-01-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | −¥138m | 2022-01-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥882m | 2023-01-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥645m | 2022-01-01 → 2022-12-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥112m | 2022-01-01 → 2022-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥882m | 2023-01-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥209m | 2022-01-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥797m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.3bn | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥144m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥788m | 2023-01-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | −¥180m | 2022-01-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥53.8bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥55.5bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥50.7bn | at 2022-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥33.7bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥35.9bn | at 2022-12-31 | Cons. | Liabilities |
| Net assets / equity | ¥20.1bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥19.6bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥21.5bn | at 2022-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥716m | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥899m | at 2022-12-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥13.7 | 2023-01-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-21.22 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.42 | 2022-01-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 34.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.4% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-01-01 → 2023-03-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-01-01 → 2023-03-31 | ¥20m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥921m |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥921m |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥265m |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥18.3bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥18.3bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥485m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥252m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥252m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | segment profit | 2023-01-01 → 2023-03-31 | ¥130m |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥1.3bn |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥6m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥20.8bn |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥20.8bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-03-31 | ¥0 |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | ¥875m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-01-01 → 2022-03-31 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-01-01 → 2022-03-31 | ¥16m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-01-01 → 2022-03-31 | ¥6m |
| Reconciling Itemsreconciling | revenue | 2022-01-01 → 2022-03-31 | ¥0 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥1.0bn |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥1.0bn |
| jpcrp040300-q1r_E00397-000Enzymatic Medicinereportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥171m |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥15.4bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥15.4bn |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥0 |
| jpcrp040300-q1r_E00397-000Liquorreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥301m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥95m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥95m |
| jpcrp040300-q1r_E00397-000Real Estatereportable segment | segment profit | 2022-01-01 → 2022-03-31 | ¥53m |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue | 2022-01-01 → 2022-03-31 | ¥939m |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | revenue external | 2022-01-01 → 2022-03-31 | ¥939m |
| jpcrp040300-q1r_E00397-000Starch For Processingreportable segment | segment profit | 2022-01-01 → 2022-03-31 | −¥68m |
| —segment total | revenue | 2022-01-01 → 2022-03-31 | ¥17.5bn |
| —segment total | revenue external | 2022-01-01 → 2022-03-31 | ¥17.5bn |
| —segment total | revenue intersegment | 2022-01-01 → 2022-03-31 | ¥0 |
| —segment total | segment profit | 2022-01-01 → 2022-03-31 | −¥144m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 403
| Item | Context | Value | Unit |
|---|---|---|---|
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |